• 1
    WHO. New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec2009; 84:249257.
  • 2
    Uyeki TM. 2009 H1N1 virus transmission and outbreaks. N Engl J Med2010; 362:22212223.
  • 3
    Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine2010; 28:48954902.
  • 4
    Kelly HA, Grant KA, Williams S, Fielding J, Smith D. Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust2009; 191:146149.
  • 5
    Bin C, Xingwang L, Yuelong S et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) virus 2009 infection, People’s Republic of China, 2009. Emerg Infect Dis2009; 15:14181422.
  • 6
    Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school – New York City, April 2009. MMWR Morb Mortal Wkly Rep2009; 58:470472.
  • 7
    Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med2009; 361:19451952.
  • 8
    Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet2009; 375:4148.
  • 9
    Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med2009; 360:26052615.
  • 10
    Centers for Disease Control and Prevention. Update: influenza activity, United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep2010; 59:423430.
  • 11
    Centers for Disease Control and Prevention (CDC). FluView: week 48 ending December 5, 2009. Available at (Accessed 11 December 2009).
  • 12
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep2009; 58:18.
  • 13
    Zhu FC, Wang H, Fang HH et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med2009; 361:24142423.
  • 14
    Liang XF, Wang HQ, Wang JZ et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet2010; 375:5666.
  • 15
    Wu J, Xu F, Lu L et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med2010; 363:24162423.
  • 16
    Wu J, Li W, Wang HQ et al. A rapid immune response to 2009 influenza A (H1N1) vaccines in adults: a randomized, double-blind, controlled trial. J Infect Dis2010; 202:675680.
  • 17
    Nolan T, McVernon J, Skeljo M et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial. JAMA2010; 303:3746.
  • 18
    Oh CE, Lee J, Kang JH et al. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial. Vaccine2010; 28:58575863.
  • 19
    Plennevaux E, Blatter M, Cornish MJ et al. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Vaccine2011; 29:15691575.
  • 20
    CBER/FDA. Regulatory Considerations Regarding the Use of Novel Influenza A (H1N1) Virus Vaccines: United States Food and Drug Administration, 2009.
  • 21
    Chen H, Wang Y, Liu W et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis2009; 15:18491850.
  • 22
    Black S, Nicolay U, Vesikari T et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J2011; 30:10811085.
  • 23
    Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill2009; 14:pii: 19288.
  • 24
    Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis2012; 12:3644.
  • 25
    Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev2008; 2:CD004879.
  • 26
    Vesikari T, Knuf M, Wutzler P et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med2011; 365:14061416.
  • 27
    Heinonen S, Silvennoinen H, Lehtinen P et al. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis2011; 11:2329.
  • 28
    Skowronski DM, Hottes TS, Chong M et al. Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics2011; 128:e276e289.